"
MDR1 Haplotypes and G2677T/A Polymorphism Predict Imatinib Response in Tunisian Patients with Chronic Myeloid Leukemia"
written by Mariam Ammar, Sonia Ktari, Moez Medhaffar, Hanen Ghozzi, Moez Elloumi, Adnen Hammami, Khaled Zeghal, Lobna Ben Mahmoud,
published by
Journal of Biosciences and Medicines,
Vol.10 No.9, 2022
has been cited by the following article(s):